Fierce Healthcare1d
DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
Eli Lilly takes actions to stop compounders from making its weight loss med
Eli Lilly ( NYSE: LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass ...
Alternative version of Ozempic, Wegovy may not be available much longer
Affordable and alternative versions of popular weigh loss drugs, like Ozempic and Wegovy, may no longer be available.
Yahoo Finance3d
Eli Lilly is coming after makers of copycat versions of Zepbound
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound. The pharmaceutical giant filed two lawsuits ...
pharmaphorum2d
Novo joins Lilly in asking FDA for ban on GLP-1 compounding
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...
Healthline3d
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
Share on Pinterest The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by ...